CTCs of at least two NSCLC patients shared variants in six oncogenes/tumor suppressor genes: NF1, TP53, SMARCB1, SMAD4, KRAS, and ERBB2. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.